Posts tagged All News
NRL records its highest ever net profit at Rs 718.31 crore (04-09-2015)
Telcos should compensate users for call drops: TRAI (04-09-2015)
![Telcos should compensate users for call drops: TRAI Telcos should compensate users for call drops: TRAI](http://www.moneycontrol.com/news_image_files/2013/t/telecom_1-1_200x200.jpg)
Towards a Capital Allocation Framework! (04-09-2015)
This is a good topic and the gist of the matter has been covered very well. However what I want to bring out is the question on how much of your networth to invest in equities? People talk about conentrated portfolio of well researched 2/3/4 stocks with strong conviction and understandig of the business. But what is the point if your equity portfolio is less than 10% of your networth? Personally based on my interaction with fellow investors equities are still a small pie of one's networth usually dominated by real estate and in some cases gold. I would like to hear and learn from investors who have more than 60% of their networth in equities and how they look at portfolio construction? Do they concentrate on a few names or diversify? What has been their experience over the past bull and bear markets?
Personally I hold a little over 30% of my networth in equities with a concentrated portfolio of 3 stocks making up 80% of it.
P.S: I have excluded the house I live, jewellery, car, etc.,while considering networth.
Hitesh portfolio (04-09-2015)
Dear @hitesh2710 : Do you track Lincoln Pharma?
Here are some quick notes:
Lincoln Pharma established in 1979 has its plant located in Ahmedabad.They are present in 51 countries (predominantly Africa, Central Americas & Central Asia) but not in regulated markets. 55% of their revenues come from International markets. Here is the break-up of their revenues from various segments:
General anti-infectives - 25%
Respiratory Systems - 20%
Alimentary Tract & Metabolism -20%
Genito Urinary + Sex hormones - 12%
Others- 33%(the break-up is available in Investor presentation)
This is a micro-cap with a mcap of about 200 crores. On a TTM basis the company is available at a P/E of ~11.88.(low P/E is due to lack-lustre sales growth i think for the past many years) The company's sales growth over the last many years has not been very impressive, but there are some recent positive developments.
Recent Developments:
1. Company has tripled its Unit 1's capacity.(has 2 units)
2. Acquires 36.58% stake from Lincoln parental - This is a key development as it offers Lincoln capability to develop complete range of product under therapeutic group like Tablet, Capsule, Ointment, Injectable, Syrup, Dry Powder under Lincoln Pharmaceuticals Ltd
3. Debt reduction
I have also attached their Q1 investor presentation for your reference. LPL-2015-16-Qtr.-1-Business-Presentation.pdf (1.2 MB)
Will the above developments mean a meaningful turnaround for Lincoln?
The below snapshot also has the list of their brands. Are these run-of-the-mill products which doesn't give this company an edge? (sourced from their investor presentation)
Thanks,
Ravi S
Disc - No positions in Lincoln
Prime Minister Modi meets RSS leaders to mend ties (04-09-2015)
![Prime Minister Modi meets RSS leaders to mend ties Prime Minister Modi meets RSS leaders to mend ties](http://www.moneycontrol.com/news_image_files/2015/m/modi_uae_200x200.jpg)